Early progression of breast cancer during neoadjuvant chemotherapy may predict poorer prognoses.
Conclusions: An early MRI assessment after two NACT cycles, specifically of the tumour's axillary lymph nodes, has the potential to predict short-term BCSS in patients with locally advanced HER2-negative breast cancers.
PMID: 32394761 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Myller S, Ipatti P, Jääskeläinen A, Haapasaari KM, Jukkola A, Karihtala P Tags: Acta Oncol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Finland Health | HER2 | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | PET Scan